Huapont Launches Generic Zyvox and Avelox

2019-10-08

Download

Recently, HUAPONT`s Linezolid Tablet 600mg and Moxifloxacin HCl Tablet 400mg have both
passed the BE(Bio-Equivalence) study in China, told by HUAPONT`s Clinical Study Centre. The
clinical results show HUAPONT drugs are bioequivalence as compared with the RLD(Reference
Listed Drugs) PHARMACIA AND UPJOHN ZYVOX 600mg and BAYER AVELOX
400mg,respectively. Now, we have not only finished the research and development of API and FDF but also approved
by local Authority. Next, we are planning to register our high-quality products to overseas and
welcome the international organizations to audit our first-class workshops. As the CTD dossiers
ready, we are now also looking forward to receiving any kinds of finished product co-operations
from you!
Please do not hesitate to contact us:
Email: mike.wang@huapont.cn
Tel: 0086-23-67886928 | Fax: 0086-23-67886927
www.huapont.cn
About HUAPONT
Founded in 1992, HUAPONT is one of the fastest-growing listed pharmaceutical companies with annual sales over $162M (¥
1.08Billion) in 2016.Headquarter located in Chongqing, HUAPONT has one R&D center, two API plants and two FDF factories, with more than 1,836 dedicated personnels working across these facilities.HUAPONT’s strength lies in dermatology, respiratory &
oncology products. About PHARMACIA AND UPJOHN
In 1995, Pharmacia & Upjohn was formed through the merger of Pharmacia AB and The Upjohn Company. Pharmacia & Upjohn
became a global provider of human health care products, animal health products, diagnostics and specialty products. In 1998, Pharmacia & Upjohn relocated its global headquarters from the United Kingdom to the United States. In April 2000, Pharmacia & Upjohn completed a merger with Monsanto and Searle creating Pharmacia, a dynamic new competitor
in the pharmaceutical industry. This top-tier company's innovative medicines and other products saved the lives of many and
enhanced health and wellness. Following the merger, Pharmacia continued Searle's agreement with Pfizer to co-promote Celebrex, which was originally co-developed by Searle and Pfizer. About BAYER
Bayer was founded in Barmen in 1863. It was part of IG Farben, the world's largest chemical and pharmaceutical company, from
1925 to 1952, and then again became an independent company. The company played a key role in the Wirtschaftswunder during
the early Cold War and quickly regained its position as one of the world's largest chemical and pharmaceutical corporations. Bayer acquired Schering in 2006 and announced its acquisition of Monsanto in 2016; the merger is still pending approval.